Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Green

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
The Annals of Pharmacotherapy|March 17, 2005
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs, Clive Kearon, Jim A Julian, et al.
Plos One|April 16, 2011
Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanismsG R Scott Budinger, Joanne L McKell, Daniela Urich, et al.
Vascular Medicine (London, England)|December 10, 2015
Changes in D-dimer and inflammatory biomarkers before ischemic events in patients with peripheral artery disease: The BRAVO StudyMary McGrae McDermott, Kiang Liu, David Green, et al.
Global Change Biology|April 17, 2021
Current and future carbon stocks in coastal wetlands within the Great Barrier Reef catchmentsMicheli Duarte de Paula Costa, Catherine E Lovelock, Nathan J Waltham, et al.
Vascular Medicine (London, England)|February 14, 2016
Community walking speed, sedentary or lying down time, and mortality in peripheral artery diseaseMary M McDermott, Jack M Guralnik, Luigi Ferrucci, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
American Journal of Hematology|February 8, 2022
Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodiesAdam J Kanack, Bandana Singh, Gemlyn George, et al.
Blood|May 22, 2013
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing ProjectJill M Johnsen, Paul L Auer, Alanna C Morrison, et al.
Human Molecular Genetics|June 17, 2011
A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) ConsortiumKira C Taylor, Leslie A Lange, Delilah Zabaneh, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
The Annals of Pharmacotherapy|March 17, 2005
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs, Clive Kearon, Jim A Julian, et al.
Plos One|April 16, 2011
Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanismsG R Scott Budinger, Joanne L McKell, Daniela Urich, et al.
Vascular Medicine (London, England)|December 10, 2015
Changes in D-dimer and inflammatory biomarkers before ischemic events in patients with peripheral artery disease: The BRAVO StudyMary McGrae McDermott, Kiang Liu, David Green, et al.
Global Change Biology|April 17, 2021
Current and future carbon stocks in coastal wetlands within the Great Barrier Reef catchmentsMicheli Duarte de Paula Costa, Catherine E Lovelock, Nathan J Waltham, et al.
Vascular Medicine (London, England)|February 14, 2016
Community walking speed, sedentary or lying down time, and mortality in peripheral artery diseaseMary M McDermott, Jack M Guralnik, Luigi Ferrucci, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
American Journal of Hematology|February 8, 2022
Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodiesAdam J Kanack, Bandana Singh, Gemlyn George, et al.
Blood|May 22, 2013
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing ProjectJill M Johnsen, Paul L Auer, Alanna C Morrison, et al.
Human Molecular Genetics|June 17, 2011
A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) ConsortiumKira C Taylor, Leslie A Lange, Delilah Zabaneh, et al.
Pageof 26